An open-label, multicenter phase 2 study (NCT03973112) conducted in China aimed to investigate the safety and initial effectiveness of serplulimab...
IRVINE, Calif., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Helio Genomics ("Helio” or "the Company”), an AI-driven healthcare company specializing in...
The left panel illustrates the living cycle, including regular health care visits. The right panel depicts the process of adjusting...
Hepatocellular carcinoma (HCC) is a primary malignancy of the liver and one of the leading causes of cancer-related deaths worldwide....
Dublin, May 07, 2024 (GLOBE NEWSWIRE) -- The "Unresectable Hepatocellular Carcinoma Global Market Report 2024" report has been added to...
DescriptiveOverall, in England 23,555 HCCs were diagnosed between 2006 and 2017. 36.1% of these presented via an emergency route, 30.2%...
